Recruiting
REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)
About this study
The purpose of this study is to evaluate safety of REXULTI in patients under daily clinical settings. In addition, information on efficacy will be collected.
- Condition
- Alzheimer Disease
- Tested
- Brexpiprazole (Rexulti)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
Who can join
- Age
- 15 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Minimum age: 15 years
- Study condition: Alzheimer Disease
- Patients diagnosed with Alzheimer's disease
Where
1 site, 1 recruiting
Pharmacovigilance Department
Osaka, Osaka, Japan
Contact
-
Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
+81-6-6943-7722 komaniwa.satoshi@otsuka.jp
Potential match only. Final eligibility is determined by the study team.